PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC13231543::ACT047757

sP10

Evidence text

Paper-level observation

the clonal formation assay showed that P10 and sP10 decreased the number of clones formed by SK-Hep1 and Hepa1-6 cells (Fig. 3B).
figureConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Not reported by source
Measure
qualitative
Comparator
range
Raw observation
decreased the number of clones
Normalized measurement
1–6
Value minimum
1
Value maximum
6
Target
Hepa1-6
Assay method
Not reported by source
Sequence
YGRKKRRQRRRCGPVWFLIFSYFLFFSISLARGPC
Standardization
ready simple

Source publication

Peptide aptamer sP10 targeting NPM1 attenuates liver fibrosis and hepatocellular carcinoma.

Journal of Translational Medicine · 2026

DOI 10.1186/s12967-026-08144-8 PMC13231543
Parent mention

Related peptide identities

PEPDIA-PLP-003251

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.